Hisamitsu Pharmaceutical Co., Inc. (FRA:HPX)
Germany flag Germany · Delayed Price · Currency is EUR
23.00
+0.20 (0.88%)
Last updated: Dec 5, 2025, 8:03 AM CET

Hisamitsu Pharmaceutical Co. Company Description

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan.

The company offers OTC products, such as, external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete′s foot; and ALLEGRA FX, a sinus medication for allergies.

It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders.

It also exports its products to Asia, the United States, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.

Hisamitsu Pharmaceutical Co., Inc.
Country Japan
Founded 1847
Industry Pharmaceutical Preparations
Employees 2,799
CEO Kazuhide Nakatomi

Contact Details

Address:
Tashirodaikan-machi 408
Tosu, 841-0017
Japan
Phone 81 3 5293 1720
Website global.hisamitsu

Stock Details

Ticker Symbol HPX
Exchange Frankfurt Stock Exchange
Stock Type Common Stock
Fiscal Year March - February
Reporting Currency JPY
SIC Code 2834

Key Executives

Name Position
Kazuhide Nakatomi Chief Executive Officer